Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Clarus Ventures III GP, L.P. — Aptiv Solutions, Inc. insider: 1 transactions · InsiderLens

/ / Clarus Ventures III GP, L.P.

Clarus Ventures III GP, L.P.

10% owner at Tourmaline Bio, Inc. · on record since May 14, 2021
10% owner at Forty Seven, Inc. · on record since Jun 27, 2018
10% owner at Aptiv Solutions, Inc. · on record since Jun 25, 2018
10% owner at Gritstone bio, Inc. · on record since Sep 27, 2018
10% owner at Entasis Therapeutics Holdings Inc. · on record since Sep 25, 2018
General Partner at Gritstone bio, Inc. · on record since Oct 2, 2018
10% owner at Annexon, Inc. · on record since Jul 30, 2020
10% owner at CALIFORNIA COASTAL COMMUNITIES INC · on record since Sep 25, 2020
10% owner at Praxis Precision Medicines, Inc. · on record since Oct 22, 2020
10% owner at EPIX Pharmaceuticals, Inc. · on record since Oct 1, 2020
10% owner at Imago BioSciences, Inc. · on record since Jul 20, 2021

Insider trading activity of Clarus Ventures III GP, L.P.

Transactions on record: 1; since May 22, 2019

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 22, 2019

Figures computed from official regulatory filings — .

Companies where Clarus Ventures III GP, L.P. has traded

Aptiv Solutions, Inc.1 tx · May 22, 2019

Track record of Clarus Ventures III GP, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Clarus Ventures III GP, L.P.

Co-insiders of Clarus Ventures III GP, L.P.

This page republishes public regulatory disclosures.

Clarus Lifesciences III, L.P.Annexon, Inc. +9

Blackstone Group L.P.Annexon, Inc. +8

Blackstone Group Management L.L.C.Annexon, Inc. +8

Blackstone Holdings I/II GP IncAnnexon, Inc. +8

Blackstone Holdings II L.P.Annexon, Inc. +8

SCHWARZMAN STEPHEN AAnnexon, Inc. +8

Blackstone Clarus III L.L.C.Annexon, Inc. +7

Clarus Ventures III, LLCAptiv Solutions, Inc. +3

GALAKATOS NICHOLASEntasis Therapeutics Holdings Inc. +3

Requadt ScottAptiv Solutions, Inc. +3

HENNER DENNISEntasis Therapeutics Holdings Inc. +2

Simon NicholasEntasis Therapeutics Holdings Inc. +2

Blackstone Holdings I L.P.Praxis Precision Medicines, Inc. +1

CLARK IAN TAptiv Solutions, Inc. +1

Green JeremyAnnexon, Inc. +1

Heron Patrick JEntasis Therapeutics Holdings Inc. +1

LIPTAK ROBERTEntasis Therapeutics Holdings Inc. +1

MACKAY GEOFFREYAptiv Solutions, Inc. +1

Norden GregoryEntasis Therapeutics Holdings Inc. +1

Novo A/SEntasis Therapeutics Holdings Inc. +1

Redmile Group, LLCAnnexon, Inc. +1

WHEELER KURTEntasis Therapeutics Holdings Inc. +1

Adage Capital Management, L.P.Praxis Precision Medicines, Inc.

Agarwala SandipTourmaline Bio, Inc.

Agarwal ShefaliGritstone bio, Inc.

ALAFI CAPITAL CO LLCCALIFORNIA COASTAL COMMUNITIES INC

ALBERTS KELLYAptiv Solutions, Inc.

Allen Andrew RGritstone bio, Inc.

ALLOCCA TONYAptiv Solutions, Inc.

Altarac DavidEntasis Therapeutics Holdings Inc.

Aphale JayantGritstone bio, Inc.

Arbuckle Stuart APraxis Precision Medicines, Inc.

Arenberg MichaelImago BioSciences, Inc.

ARENS GEOFFREY WCALIFORNIA COASTAL COMMUNITIES INC

ARTIS DEAN RICHARDAnnexon, Inc.

ASTRAZENECA ABEntasis Therapeutics Holdings Inc.

ASTRAZENECA PLCEntasis Therapeutics Holdings Inc.

ASTRUE MICHAEL JEPIX Pharmaceuticals, Inc.

Atchinson RobertPraxis Precision Medicines, Inc.

Atlas Venture Associates Opportunity I, LLCAptiv Solutions, Inc.

Atlas Venture Associates Opportunity I, L.P.Aptiv Solutions, Inc.

Atlas Venture Associates X, LLCAptiv Solutions, Inc.

ATLAS VENTURE ASSOCIATES X, L.P.Aptiv Solutions, Inc.

Atlas Venture Fund X, L.P.Aptiv Solutions, Inc.

Atlas Venture Opportunity Fund I, L.P.Aptiv Solutions, Inc.

Avruch StevenAptiv Solutions, Inc.

Bain Capital Life Sciences Fund, L.P.Annexon, Inc.

Bain Capital Life Sciences Investors, LLCAnnexon, Inc.

Bain Capital Life Sciences Partners, LPAnnexon, Inc.

BALL KRISTINE MForty Seven, Inc.

Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
Aptiv Solutions, Inc.Listing unverified	May 22, 2019	Other	-1,481,163	—	n/a (No price was disclosed in the filing)		SEC